Agios Pharm Stock Target Price and Analyst Consensus
| AGIO Stock | USD 55.68 0.14 0.25% |
The current analyst and expert consensus on Agios Pharm is Buy, with 3 strong buy opinions. The current projected Agios Pharm target price consensus is 39.00 with 10 analyst opinions. Check out Macroaxis Advice on Agios Pharm to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.The most common way Agios Pharm analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Agios Pharm executives and customers to further validate their buy or sell advice. Agios Pharm buy-or-sell recommendation module provides average expert sentiment on the projected Agios Pharm target price to derive its highest and lowest estimates based on projected price volatility of 2.9586.
Lowest Forecast 35.49 | Highest Forecast 43.29 | Target Price 39 |
Agios |
It's important to approach Agios Pharm's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Agios Pharm price targets
Agios Pharm's stock target price is an estimate of its future price, usually made by analysts. Using Agios Pharm's target price to determine if it is a suitable investment can be done through the following steps:- Look at Agios Pharm's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Agios Pharm's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Agios Pharm Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Agios Pharm is a key component of Agios Pharm valuation and have some predictive power on the future returns of a Agios Pharm.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | FinTech Invested over 60 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Cash Cows Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Chemicals Invested over 30 shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | ESG Investing Invested few shares |
Check out Macroaxis Advice on Agios Pharm to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.